Table 2. Clinical data during the experimental period.
| CIT | IIT | p | ||
|---|---|---|---|---|
| Treatment effect | Treatment × protocol interaction |
|||
| SAP (mmHg) | 143±5 | 136±6 | 0.95 | 0.81 |
| DAP (mmHg) | 67±2 | 65±3 | 0.46 | 0.33 |
| Heart rate (beats×min-1) | 86±3 | 83±4 | 0.37 | 0.77 |
| Hematocrit (%) | 33±1 | 32±2 | 0.78 | 0.15 |
| Hemoglobin (g×ml-1) | 11.6±0.4 | 11.2±0.7 | 0.18 | 0.002 |
| Platelets (109×L-1) | 218±23 | 213±25 | 0.89 | 0.51 |
| Leucocytes (109×L-1) | 11.5±1.8 | 10.1±1.6 | 0.40 | 0.07 |
| Sodium (mmol×L-1) | 138±1 | 138±1 | 0.72 | 0.55 |
| Potassium (mmol×L) | 3.71±0.07 | 3.92±0.10 | 0.49 | 0.11 |
| Creatinine (mg×dL-1) | 0.76±0.08 | 0.78±0.09 | 0.79 | 0.17 |
| Urea (mg×dL-1) | 31.0±2.1 | 33.2±3.6 | 0.49 | 0.53 |
Data are expressed as means±SEMs. SAP, systolic arterial pressure; DAP, diastolic arterial pressure. Data were analyzed with repeated measures ANOVA, with time as within subject variables (day 1 or day 2, after surgery) and sequence of treatments as between subject factors [Protocol 1 (n = 5), intensive insulin therapy (IIT) first, conventional insulin therapy (CIT) second; protocol 2 (n = 5), CIT first, IIT second)].